Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1139-1152

  Farazuddin, Mohammad ^a   Dua, Bhavyata ^b   Zia, Qamar ^a   Khan, Aijaz Ahmad ^c   Joshi, Beenu ^b   Owais, Mohammad ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^c ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cancer; Carcinogenesis; Curcuma longa; Diferuloylmethane; Microparticle; Nanocells

Indexed keywords

CURCUMIN; POLYGLACTIN; ANTINEOPLASTIC AGENT; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; ERYTHROCYTE; FEMALE; HEMOLYSIS; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; MICROCELL; MICROENCAPSULATION; MOUSE; NONHUMAN; RABBIT; SLOW DRUG RELEASE; TUMOR REGRESSION; ANIMAL; BIOAVAILABILITY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; NANOMEDICINE; PATHOLOGY; PHYTOTHERAPY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; CELL SURVIVAL; CURCUMIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; HEP G2 CELLS; HEPATOCYTES; HUMANS; LACTIC ACID; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NANOMEDICINE; NANOPARTICLES; PHYTOTHERAPY; POLYGLYCOLIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896045336     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34668     Document Type: Article

References (34)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80(6):827-841.
2. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol. 1997;8(2):117-136.
3. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206-217.
4. Inano H, Onoda M, Inafuku N, et al. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis. 1999;20(6):1011-1018.
5. Chuang SE, Kuo ML, Hsu CH, et al. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis. 2000;21(2):331-335.
6. Singh SV, Hu X, Srivastava SK, et al. Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis. 1998;19(8):1357-1360.
7. Li N, Chen X, Liao J, et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA) induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23(8):1307-1313.
8. Kawamori T, Lubet R, Steele VE, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999;59(3): 597-601.
9. Verma RK, Pandya S, Misra A. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles. J Biomed Nanotechnol. 2011;7(1):118-120.
10. Pietzyk B, Henschke K. Degradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditions. Int J Pharm. 2000;196(2):215-218.
11. Jain AK, Das M, Swarnakar NK, Jain S. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst. 2011;28(1):1-45.
12. Riganti C, Voena C, Kopecka J, et al. Liposome-encapsulated doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells. Mol Pharm. 2011;8(3):683-700.
13. Farazuddin M, Chauhan A, Khan RM, Owais M. Amoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice. Biosci Rep. 2011;31(4):265-272.
14. Jeffery H, Davis SS, O'Hagan DT. The preparation and characterization of PLGA microspheres: II. The entrapment of model protein using (water in oil) in water emulsion solvent evaporation technique. Pharm Res. 1993;10(3):362-368.
15. Farazuddin M, Sharma B, Khan AA, Joshi B, Owais M. Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles. Int J Nanomedicine. 2012;7:35-47.
16. Khan MA, Nasti TH, Saima K, et al. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. FEMS Immunol Med Microbiol. 2004;41(3):249-258.
17. Jayaprakasha GK, Rao LJM, Sakariah KK. Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisde methoxycurcumin. J Agric Food Chem. 2002;50(13):3668-3672.
18. Khan MA, Syed FM, Nasti, et al. Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B. J Drug Target. 2002;11(2):93-99.
19. Pitot HC, Barsness L, Goldsworthy T, Kitagawa T. Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature. 1978;271(5644):456-458.
20. Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985;29(2): 197-202.
21. Carr BI, Pancoska P, Branch RA. Significance of increased serum GGTP levels in HCC patients. Hepatogastroenterology. 2010;57(101): 869-874.
22. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71(10): 1397-1421.
23. Chauhan A, Swaleha Z, Ahmad N, et al. Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity. Vaccine. 2011;29(33):5424-5433.
24. Serpi R, Piispala J, Jarvilehto M, Vahakangas K. Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene DNA adducts as TPA in mouse skin. Carcinogenesis. 1999;20(9):1755-1760.
25. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci. 1979;76(9):4350-4354.
26. Lowry OH, Rosenbrough NK, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193(1):265-275.
27. Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology. 2007;5:3.
28. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104(6):1322-1331.
29. Aggarwal BB, Shishodia S, Takada Y, et al. TNF blockade: an inflammatory issue. Ernst Schering Res Found Workshop. 2006;56:161-186.
30. Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005;223(2):181-190.
31. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A): 363-398.
32. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem. 2005;280(20):20059-20068.
33. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci. 2000;910:121-137.
34. Cory S, Huang CSD, Adams MJ. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003;22(53):8590-8607.